SAMANTHA SCHROEDER: Open Payments
NPI 1538472550 · SPRING HILL, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 39 payments from 7 companies in 2025. Trend: 2023 $520 · 2024 $361 · 2025 $686
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $200 |
| ABBVIE INC. | 20 | $177 |
| Lilly USA, LLC | 4 | $87 |
| Supernus Pharmaceuticals, Inc. | 5 | $85 |
| Axsome Therapeutics, Inc. | 4 | $75 |
| Novo Nordisk Inc | 3 | $46 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: AIRSUPRA, VRAYLAR, MOUNJARO, Qelbree, Auvelity, Ozempic, QULIPTA, AREXVY.
Industry payments across KS — which companies pay providers there.
